Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BETA DRUGS vs EVEREST ORGANICS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BETA DRUGS EVEREST ORGANICS BETA DRUGS /
EVEREST ORGANICS
 
P/E (TTM) x - -20.6 - View Chart
P/BV x 12.8 2.4 539.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BETA DRUGS    EVEREST ORGANICS
EQUITY SHARE DATA
    BETA DRUGS
Mar-24
EVEREST ORGANICS
Mar-24
BETA DRUGS /
EVEREST ORGANICS
5-Yr Chart
Click to enlarge
High Rs1,595162 986.4%   
Low Rs64595 678.4%   
Sales per share (Unadj.) Rs307.7210.0 146.5%  
Earnings per share (Unadj.) Rs37.90.2 21,822.0%  
Cash flow per share (Unadj.) Rs48.17.4 648.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs163.557.3 285.3%  
Shares outstanding (eoy) m9.618.00 120.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.60.6 595.6%   
Avg P/E ratio x29.5737.4 4.0%  
P/CF ratio (eoy) x23.317.3 134.6%  
Price / Book Value ratio x6.92.2 305.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m10,7651,027 1,048.4%   
No. of employees `000NANA-   
Total wages/salary Rs m201188 107.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,9571,680 176.0%  
Other income Rs m149 162.9%   
Total revenues Rs m2,9721,689 176.0%   
Gross profit Rs m599110 545.3%  
Depreciation Rs m9858 168.8%   
Interest Rs m2855 51.6%   
Profit before tax Rs m4886 7,992.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1235 2,615.1%   
Profit after tax Rs m3641 26,213.7%  
Gross profit margin %20.36.5 309.8%  
Effective tax rate %25.377.2 32.7%   
Net profit margin %12.30.1 14,870.1%  
BALANCE SHEET DATA
Current assets Rs m1,8761,500 125.1%   
Current liabilities Rs m9441,601 59.0%   
Net working cap to sales %31.5-6.0 -523.3%  
Current ratio x2.00.9 212.1%  
Inventory Days Days137 171.6%  
Debtors Days Days9782,175 45.0%  
Net fixed assets Rs m748767 97.5%   
Share capital Rs m9680 120.2%   
"Free" reserves Rs m1,475378 389.8%   
Net worth Rs m1,571458 342.8%   
Long term debt Rs m60146 41.3%   
Total assets Rs m2,6242,267 115.7%  
Interest coverage x18.31.1 1,645.3%   
Debt to equity ratio x00.3 12.0%  
Sales to assets ratio x1.10.7 152.1%   
Return on assets %15.02.5 605.0%  
Return on equity %23.20.3 7,637.0%  
Return on capital %31.610.0 314.6%  
Exports to sales %15.027.7 54.2%   
Imports to sales %0.410.9 3.2%   
Exports (fob) Rs m445466 95.5%   
Imports (cif) Rs m10184 5.7%   
Fx inflow Rs m445466 95.4%   
Fx outflow Rs m41187 22.1%   
Net fx Rs m404280 144.4%   
CASH FLOW
From Operations Rs m309164 188.4%  
From Investments Rs m-140-133 104.9%  
From Financial Activity Rs m-75-31 241.7%  
Net Cashflow Rs m950 -946,900.0%  

Share Holding

Indian Promoters % 66.7 72.0 92.6%  
Foreign collaborators % 0.0 2.1 -  
Indian inst/Mut Fund % 1.3 0.0 4,333.3%  
FIIs % 1.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 33.3 25.9 128.7%  
Shareholders   2,567 9,996 25.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BETA DRUGS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on BETA DRUGS vs EVEREST ORGANICS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BETA DRUGS vs EVEREST ORGANICS Share Price Performance

Period BETA DRUGS EVEREST ORGANICS S&P BSE HEALTHCARE
1-Day 5.14% -6.64% 1.23%
1-Month 5.14% 14.67% -0.24%
1-Year 5.14% 15.70% 43.62%
3-Year CAGR 1.68% -19.82% 20.35%
5-Year CAGR 1.01% -5.19% 26.24%

* Compound Annual Growth Rate

Here are more details on the BETA DRUGS share price and the EVEREST ORGANICS share price.

Moving on to shareholding structures...

The promoters of BETA DRUGS hold a 66.7% stake in the company. In case of EVEREST ORGANICS the stake stands at 74.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BETA DRUGS and the shareholding pattern of EVEREST ORGANICS.

Finally, a word on dividends...

In the most recent financial year, BETA DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

EVEREST ORGANICS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BETA DRUGS , and the dividend history of EVEREST ORGANICS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.